Literature DB >> 18620380

Selectivity determinants of inhibitor binding to human 20alpha-hydroxysteroid dehydrogenase: crystal structure of the enzyme in ternary complex with coenzyme and the potent inhibitor 3,5-dichlorosalicylic acid.

Urmi Dhagat1, Satoshi Endo, Rie Sumii, Akira Hara, Ossama El-Kabbani.   

Abstract

The crystal structure of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) in ternary complex with the coenzyme NADP (+) and the potent inhibitor 3,5-dichlorosalicylic acid was determined at a resolution of 1.8 A. The inhibitor is held in place by a network of hydrogen bonding interactions with the active site residues Tyr55, His117, and His222. The important role of the nonconserved residues Leu54, His222, Leu306, and Leu308 in inhibitor binding and selectivity was determined by site-directed mutagenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620380     DOI: 10.1021/jm8003575

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

Review 1.  Human hydroxysteroid dehydrogenases and pre-receptor regulation: insights into inhibitor design and evaluation.

Authors:  Trevor M Penning
Journal:  J Steroid Biochem Mol Biol       Date:  2011-01-25       Impact factor: 4.292

Review 2.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

3.  Design and development of novel inhibitors of aldo-ketoreductase 1C1 as potential lead molecules in treatment of breast cancer.

Authors:  Priyanka Verma; Md Imtaiyaz Hassan; Archana Singh; Indrakant K Singh
Journal:  Mol Cell Biochem       Date:  2021-03-26       Impact factor: 3.396

4.  Control of steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the hypothalamic-pituitary-adrenal axis.

Authors:  Ting Wang; Yatrik M Shah; Tsutomu Matsubara; Yueying Zhen; Tomotaka Tanabe; Tomokazu Nagano; Serge Fotso; Kristopher W Krausz; T Mark Zabriskie; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

5.  AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent manner.

Authors:  Lin-Lin Chang; Yue-Kang Li; Chen-Xi Zhao; Chen-Ming Zeng; Fu-Jing Ge; Jia-Min Du; Wen-Zhou Zhang; Pei-Hua Lu; Qiao-Jun He; Hong Zhu; Bo Yang
Journal:  Acta Pharmacol Sin       Date:  2021-05-20       Impact factor: 6.150

6.  AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway.

Authors:  Xianjun Wang; Baocheng Yang; Yuyu Li; Jiye Luo; Yanli Wang
Journal:  Mol Med Rep       Date:  2021-09-30       Impact factor: 2.952

7.  AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.

Authors:  Hong Zhu; Lin-Lin Chang; Fang-Jie Yan; Yan Hu; Chen-Ming Zeng; Tian-Yi Zhou; Tao Yuan; Mei-Dan Ying; Ji Cao; Qiao-Jun He; Bo Yang
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.